X
06Oct

Client Conversations: Interview with Matthew J. Maletta, Executive Vice President and Chief Legal Officer of Endo Pharmaceuticals

K&L Gates LLP | | Return|
In this episode, we interview Matthew Maletta, executive vice president and chief legal officer of Endo Pharmaceuticals. Matthew was appointed in May 2015 to these roles at Endo Pharmaceuticals, where he has global responsibility for all legal matters affecting the company. Prior to joining Endo in 2015, he served as vice president, associate general counsel, and corporate secretary of Allergan. In this position, he served as an advisor to the chief executive officer and board of directors and...
By: K&L Gates LLP
Source Url: https://www.jdsupra.com/legalnews/client-conversations-interview-with-21704/

Related

Supreme Court Rules that Employers May Use Religious and Moral Exemptions for Requirement to Provide Health Plan Coverage for Contraceptives

On July 8, 2020, in the consolidated cases of Little Sisters of the Poor Saints Peter and Paul Home ...

Read More >

Ultimate Guide to Closing a Private Equity Transaction

This is the fourth article in our series on “Closing a Private Equity Transaction.” In Part I, the...

Read More >

Refusal to Work Can Be Protected Concerted Activity

The National Labor Relations Act guarantees employees the right to engage in protected concerted act...

Read More >

Financial Daily Dose 11.16.2020 | Top Story: PNC Financial Reaches $11.6B Deal to Buy BBVA American Operations

Pittsburgh-based PNC Financial Services Group has reached a deal worth some $11.6 billion to buy the...

Read More >

[Audio] Employment Law Now: Volume 3 Episode 45- Part 1 of 2 Back From The Summer Hiatus

We begin the second half of 2019 with the 1st of 2 parts on significant employment law trends and ca...

Read More >

SEC Revises Rules for Financial Statements Required for Acquisitions and Dispositions of Businesses and Real Estate

In May 2020, the Securities and Exchange Commission approved amendments to the requirements for fina...

Read More >